MEDCARE: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDCARE
Largest movements
- Cash +€33,321
up €33,321 (+55.3%), from €60,254 to €93,575
mainly Net result for the year (+€32,955) and Other debts (+€32,584)
- Tangible fixed assets +€22,657
up €22,657 (+399.7%), from €5,669 to €28,326
of which Plant, machinery and equipment: +€19,979
- Deferred charges and accrued income +€5,209
up €5,209 (+86.4%), from €6,029 to €11,238
- Other debts +€32,584
up €32,584 (+50.1%), from €65,000 to €97,584
- Accrued charges and deferred income +€27,981
up €27,981 (+39847.1%), from €70 to €28,051
- Gross operating margin -€28,953
down €28,953 (-43.3%), from €66,905 to €37,952
- Depreciation +€3,240
up €3,240 (+4001.4%), from €81 to €3,321
- Other operating charges +€1,423
new in 2025: €1,423
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €73,259 | €134,403 | +€61,144 | +83.5% |
| Fixed assets | 21/28 | €5,669 | €28,326 | +€22,657 | +399.7% |
| Tangible fixed assets | 22/27 | €5,669 | €28,326 | +€22,657 | +399.7% |
| Plant, machinery and equipment | 23 | €5,669 | €25,648 | +€19,979 | +352.4% |
| Furniture and vehicles | 24 | - | €2,677 | +€2,677 | |
| Current assets | 29/58 | €67,590 | €106,077 | +€38,487 | +56.9% |
| Amounts receivable within one year | 40/41 | €1,307 | €1,264 | -€43 | -3.3% |
| Other amounts receivable | 41 | €1,307 | €1,264 | -€43 | -3.3% |
| Cash at bank and in hand | 54/58 | €60,254 | €93,575 | +€33,321 | +55.3% |
| Deferred charges and accrued income | 490/1 | €6,029 | €11,238 | +€5,209 | +86.4% |
| Total equity and liabilities | 10/49 | €73,259 | €134,403 | +€61,144 | +83.5% |
| Equity | 10/15 | €7,146 | €8,102 | +€955 | +13.4% |
| Contributions | 10/11 | €6,000 | €6,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,146 | €2,102 | +€955 | +83.3% |
| Amounts payable | 17/49 | €66,112 | €126,301 | +€60,189 | +91.0% |
| Amounts payable within one year | 42/48 | €66,042 | €98,250 | +€32,208 | +48.8% |
| Trade debts | 44 | €395 | €497 | +€102 | +25.9% |
| Suppliers | 440/4 | €395 | €497 | +€102 | +25.9% |
| Taxes, remuneration and social security | 45 | €647 | €169 | -€479 | -73.9% |
| Taxes | 450/3 | €647 | €169 | -€479 | -73.9% |
| Other amounts payable | 47/48 | €65,000 | €97,584 | +€32,584 | +50.1% |
| Accrued charges and deferred income | 492/3 | €70 | €28,051 | +€27,981 | +39847.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €81 | €3,321 | +€3,240 | +4001.4% |
| Other operating charges | 640/8 | - | €1,423 | +€1,423 | |
| Gross operating margin | 9900 | €66,905 | €37,952 | -€28,953 | -43.3% |
| Operating profit (loss) | 9901 | €66,824 | €33,209 | -€33,615 | -50.3% |
| Financial income | 75/76B | - | €1 | +€1 | |
| Recurring financial income | 75 | - | €1 | +€1 | |
| Financial charges | 65/66B | €30 | €86 | +€56 | +184.3% |
| Recurring financial charges | 65 | €30 | €86 | +€56 | +184.3% |
| Profit (loss) for the period before taxes | 9903 | €66,794 | €33,124 | -€33,670 | -50.4% |
| Income taxes | 67/77 | €647 | €169 | -€479 | -73.9% |
| Profit (loss) for the period | 9904 | €66,146 | €32,955 | -€33,191 | -50.2% |
| Profit (loss) for the period to be appropriated | 9905 | €66,146 | €32,955 | -€33,191 | -50.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.